{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:57:07Z","timestamp":1781636227884,"version":"3.54.5"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100024003","name":"Damanhour University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100024003","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Stano is an anabolic androgenic steroid (AAS) with various adverse cardiovascular effects because it induces ventricular dysfunction. The objective of this study was to evaluate and demonstrate how Empagliflozin (EP) and platelet-rich plasma (PRP) can reduce the cardiotoxic effects linked to Stano administration in albino rats.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Fifty-four (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200954) rats were involved in this research, the animals were randomly divided into six groups: (C, EP, PRP, Stano, SEP, and SPRP). Various cardiovascular health markers, focusing on the relationship between oxidative stress and inflammation in cardiomyopathy were evaluated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There was extensive myocardial injury and damage in the Stano group, as reflected by induction of oxidative stress by increase in the level of MDA, along with significantly reduced level of GSH and CAT. Increased expression of inflammatory markers like IL-1\u03b2, and NF-\u03baB\/P65 pathway, with strong immunoreactivity of caspase-3-an apoptosis marker in cardiac tissue were observed. Evidence of left ventricular hypertrophy with pathological changes in cardiac tissues was also noted, together with functional impairments. Hypertrophy acts as a compensatory mechanism against injury and stress, since it may cause various complications in case of a lack of intervention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Stano activates the initiation of some apoptotic and inflammatory signaling pathways to cause serious aggravated cardiovascular health threats. On the other hand, all the structural function and antioxidant parameters related to cardiovascular health showed improvement after both EP and PRP treatments. Intriguingly, EP and PRP have emerged as effective promising agents against the deleterious cardiac damage linked to Stano use. Nevertheless, more research is actually needed to explain the mechanisms and optimize clinical application or management of those exposed to ASS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40360-026-01086-3","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T18:36:59Z","timestamp":1771871819000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Empagliflozin and platelet-rich plasma improve stanozolol induced cardiotoxicity by reducing NF-\u03baB\/P65, IL-1B and apoptosis"],"prefix":"10.1186","volume":"27","author":[{"given":"Shaimaa M.","family":"Hafez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman Mohammed","family":"Elsaeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal Hussain Mohammed","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman S.","family":"Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yara S.","family":"Abouelela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa Abdo","family":"Elshiech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba Abdelnaser","family":"Aboelsoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala Magdy","family":"Anwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar H.","family":"Elsharkawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa A.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamdy","family":"Rizk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda A.","family":"Abd-Ellatieff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,23]]},"reference":[{"key":"1086_CR1","doi-asserted-by":"crossref","unstructured":"Bond P, Smit D, de Ronde W. Anabolic-androgenic steroids: How do they work and what are the risks? Front Endocrinol (Lausanne). 2022;13:1059473. In Book Anabolic-androgenic steroids: How do they work and what are the risks? Front Endocrinol (Lausanne). 2022; 13: 1059473 (Editor). City; 2022.","DOI":"10.3389\/fendo.2022.1059473"},{"key":"1086_CR2","doi-asserted-by":"crossref","unstructured":"Wenbo Z, Yan Z. The uses of anabolic androgenic steroids among athletes; its positive and negative aspects-a literature review. J Multidisciplinary Healthc 2023:4293\u2013305.","DOI":"10.2147\/JMDH.S439384"},{"key":"1086_CR3","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1002\/jor.24116","volume":"36","author":"IA Jones","year":"2018","unstructured":"Jones IA, Togashi R, Hatch GFR III, Weber AE, Vangsness CT Jr. Anabolic steroids and tendons: A review of their mechanical, structural, and biologic effects. J Orthop Research\u00ae. 2018;36:2830\u201341.","journal-title":"J Orthop Research\u00ae"},{"key":"1086_CR4","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/PAF.0000000000000424","volume":"39","author":"M Lusetti","year":"2018","unstructured":"Lusetti M, Licata M, Silingardi E, Bonsignore A, Palmiere C. Appearance\/image-and performance-enhancing drug users: a forensic approach. Am J Forensic Med Pathol. 2018;39:325\u20139.","journal-title":"Am J Forensic Med Pathol"},{"key":"1086_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jsbmb.2004.11.003","volume":"93","author":"A Beutel","year":"2005","unstructured":"Beutel A, Bergamaschi CT, Campos RR. Effects of chronic anabolic steroid treatment on tonic and reflex cardiovascular C in male rats. J Steroid Biochem Mol Biol. 2005;93:43\u20138.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1086_CR6","first-page":"e1504","volume":"6","author":"RL Harries","year":"2024","unstructured":"Harries RL, De Paoli G, Hall S, Nisbet LA. A review of the analytical techniques for the detection of anabolic\u2013androgenic steroids within biological matrices. Wiley Interdisciplinary Reviews: Forensic Sci. 2024;6:e1504.","journal-title":"Wiley Interdisciplinary Reviews: Forensic Sci"},{"key":"1086_CR7","doi-asserted-by":"crossref","unstructured":"Lynes A, Kelly C, Treadwell J. 50 dark destinations: crime and contemporary tourism. Policy; 2023.","DOI":"10.56687\/9781447362210"},{"key":"1086_CR8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.taap.2016.04.001","volume":"301","author":"N Ad","year":"2016","unstructured":"Ad N, Ed L, Brasil GA, Caliman IF, Silva Jd, Lemos VS, Andrade TUd, Bissoli NS. Serca2a and Na (+)\/Ca (2+) exchanger are involved in left ventricular function following cardiac remodelling of female rats treated with anabolic androgenic steroid. Toxicol Appl Pharmcol. 2016;301:22\u201330.","journal-title":"Toxicol Appl Pharmcol"},{"key":"1086_CR9","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/HJR.0b013e3280ecfe3e","volume":"14","author":"F Furlanello","year":"2007","unstructured":"Furlanello F, Serdoz LV, Cappato R, De Ambroggi L. Illicit drugs and cardiac arrhythmias in athletes. Eur J Cardiovasc Prev Rehabilitation. 2007;14:487\u201394.","journal-title":"Eur J Cardiovasc Prev Rehabilitation"},{"key":"1086_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.toxlet.2005.06.005","volume":"158","author":"C Maravelias","year":"2005","unstructured":"Maravelias C, Dona A, Stefanidou M, Spiliopoulou C. Adverse effects of anabolic steroids in athletes: a constant threat. Toxicol Lett. 2005;158:167\u201375.","journal-title":"Toxicol Lett"},{"key":"1086_CR11","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1161\/CIRCULATIONAHA.116.026945","volume":"135","author":"AL Baggish","year":"2017","unstructured":"Baggish AL, Weiner RB, Kanayama G, Hudson JI, Lu MT, Hoffmann U, Pope HG Jr. Cardiovascular toxicity of illicit anabolic-androgenic steroid use. Circulation. 2017;135:1991\u20132002.","journal-title":"Circulation"},{"key":"1086_CR12","doi-asserted-by":"publisher","first-page":"e12911527876","DOI":"10.33448\/rsd-v11i5.27876","volume":"11","author":"TU de Andrade","year":"2022","unstructured":"de Andrade TU, Fillho DD, da Silva CL, de Almeida Silva M, de Almeida SA, do Nascimento AM, Bissoli NS, Brasil GA, de Lima EM. Sinduces ventricular dysfunction by decreasing phospholamban phosphorylation in heart tissue of LDLr-\/-mice. Res Soc Dev. 2022;11:e12911527876\u201312911527876.","journal-title":"Res Soc Dev"},{"key":"1086_CR13","doi-asserted-by":"publisher","first-page":"109925","DOI":"10.1016\/j.forsciint.2019.109925","volume":"303","author":"S Lehmann","year":"2019","unstructured":"Lehmann S, Thomas A, Schiwy-Bochat K-H, Geyer H, Thevis M, Glenewinkel F, Rothschild MA, Andresen-Streichert H, Juebner M. Death after misuse of anabolic substances (clenbuterol, sand metandienone). Forensic Sci Int. 2019;303:109925.","journal-title":"Forensic Sci Int"},{"key":"1086_CR14","doi-asserted-by":"crossref","unstructured":"LeBar K, Wang Z. Extracellular matrix in cardiac tissue mechanics and physiology: role of collagen accumulation. Extracell Matrix-Developments Ther. 2021.","DOI":"10.5772\/intechopen.96585"},{"key":"1086_CR15","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1161\/CIRCULATIONAHA.120.045691","volume":"142","author":"M Griffin","year":"2020","unstructured":"Griffin M, Rao VS, Ivey-Miranda J, Fleming J, Mahoney D, Maulion C, Suda N, Siwakoti K, Ahmad T, Jacoby D. Empagliflozin in heart failure: diuretic and cardiorenal effects. Circulation. 2020;142:1028\u201339.","journal-title":"Circulation"},{"key":"1086_CR16","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.2337\/dci18-0033","volume":"41","author":"MJ Davies","year":"2018","unstructured":"Davies MJ, D\u2019Alessio DA, Fradkin J, Kernan WN, Mathieu C, Mingrone G, Rossing P, Tsapas A, Wexler DJ, Buse JB. Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American diabetes association (ADA) and the European association for the study of diabetes (EASD). Diabetes Care. 2018;41:2669\u2013701.","journal-title":"Diabetes Care"},{"key":"1086_CR17","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1161\/CIRCULATIONAHA.118.037778","volume":"139","author":"D Fitchett","year":"2019","unstructured":"Fitchett D, Inzucchi SE, Cannon CP, McGuire DK, Scirica BM, Johansen OE, Sambevski S, Kaspers S, Pfarr E, George JT. Empagliflozin reduced mortality and hospitalization for heart failure across the spectrum of cardiovascular risk in the EP-REG OUTCOME trial. Circulation. 2019;139:1384\u201395.","journal-title":"Circulation"},{"key":"1086_CR18","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/ejhf.1663","volume":"22","author":"M B\u00f6hm","year":"2020","unstructured":"B\u00f6hm M, Slawik J, Brueckmann M, Mattheus M, George JT, Ofstad AP, Inzucchi SE, Fitchett D, Anker SD, Marx N. Efficacy of empagliflozin on heart failure and renal outcomes in patients with atrial fibrillation: data from the EP-REG OUTCOME trial. Eur J Heart Fail. 2020;22:126\u201335.","journal-title":"Eur J Heart Fail"},{"key":"1086_CR19","doi-asserted-by":"publisher","first-page":"3396","DOI":"10.2337\/dc12-2673","volume":"36","author":"H-U H\u00e4ring","year":"2013","unstructured":"H\u00e4ring H-U, Merker L, Seewaldt-Becker E, Weimer M, Meinicke T, Woerle HJ, Broedl UC, Investigators E-RMT. Empagliflozin as add-on to Metformin plus sulfonylurea in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-Cled trial. Diabetes Care. 2013;36:3396\u2013404.","journal-title":"Diabetes Care"},{"key":"1086_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-020-01040-5","volume":"19","author":"J Sabatino","year":"2020","unstructured":"Sabatino J, De Rosa S, Tamm\u00e8 L, Iaconetti C, Sorrentino S, Polimeni A, Mignogna C, Amorosi A, Spaccarotella C, Yasuda M. Empagliflozin prevents doxorubicin-induced myocardial dysfunction. Cardiovasc Diabetol. 2020;19:1\u201311.","journal-title":"Cardiovasc Diabetol"},{"key":"1086_CR21","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.3390\/ijms24032744","volume":"24","author":"B Chalidis","year":"2023","unstructured":"Chalidis B, Givissis P, Papadopoulos P, Pitsilos C. Molecular and biologic effects of Platelet-Rich plasma (PRP) in ligament and tendon healing and regeneration: a systematic review. Int J Mol Sci. 2023;24:2744.","journal-title":"Int J Mol Sci"},{"key":"1086_CR22","doi-asserted-by":"publisher","first-page":"7914","DOI":"10.3390\/ijms25147914","volume":"25","author":"PA Everts","year":"2024","unstructured":"Everts PA, Lana JF, Alexander RW, Dallo I, Kon E, Ambach MA, van Zundert A, Podesta L. Profound properties of Protein-Rich, Platelet-Rich plasma matrices as Novel, Multi-Purpose biological platforms in tissue Repair, Regeneration, and wound healing. Int J Mol Sci. 2024;25:7914.","journal-title":"Int J Mol Sci"},{"key":"1086_CR23","doi-asserted-by":"publisher","first-page":"7794","DOI":"10.3390\/ijms21207794","volume":"21","author":"P Everts","year":"2020","unstructured":"Everts P, Onishi K, Jayaram P, Lana JF, Mautner K. Platelet-rich plasma: new performance Understandings and therapeutic considerations in 2020. Int J Mol Sci. 2020;21:7794.","journal-title":"Int J Mol Sci"},{"key":"1086_CR24","doi-asserted-by":"publisher","first-page":"241","DOI":"10.4252\/wjsc.v12.i4.241","volume":"12","author":"J Purita","year":"2020","unstructured":"Purita J, Lana JFSD, Kolber M, Rodrigues BL, Mosaner T, Santos GS, Caliari-Oliveira C, Huber SC. Bone marrow-derived products: A classification proposal\u2013bone marrow aspirate, bone marrow aspirate concentrate or hybrid? World J Stem Cells. 2020;12:241.","journal-title":"World J Stem Cells"},{"key":"1086_CR25","doi-asserted-by":"publisher","first-page":"150759","DOI":"10.1016\/j.otsm.2020.150759","volume":"28","author":"HP Huddleston","year":"2020","unstructured":"Huddleston HP, Maheshwer B, Wong SE, Chahla J, Cole BJ, Yanke AB. An update on the use of orthobiologics: use of biologics for osteoarthritis. Oper Tech Sports Med. 2020;28:150759.","journal-title":"Oper Tech Sports Med"},{"key":"1086_CR26","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.2174\/138920112800624445","volume":"13","author":"T Yuan","year":"2012","unstructured":"Yuan T, Guo S-C, Han P, Zhang C-Q, Zeng B-F. Applications of leukocyte-and platelet-rich plasma (L-PRP) in trauma surgery. Curr Pharm Biotechnol. 2012;13:1173\u201384.","journal-title":"Curr Pharm Biotechnol"},{"key":"1086_CR27","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1016\/j.joen.2014.07.022","volume":"40","author":"X Li","year":"2014","unstructured":"Li X, Hou J, Wu B, Chen T, Luo A. Effects of platelet-rich plasma and cell coculture on angiogenesis in human dental pulp stem cells and endothelial progenitor cells. J Endod. 2014;40:1810\u20134.","journal-title":"J Endod"},{"key":"1086_CR28","first-page":"378","volume":"46","author":"AA El-Shafei","year":"2023","unstructured":"El-Shafei AA, Hassan RM, Hosny SA. A comparative histological and immunohistochemical study on the possible therapeutic effects of empagliflozin and platelet-rich plasma against cisplatin induced cardiotoxicity in rats. Egypt J Histol. 2023;46:378\u2013493.","journal-title":"Egypt J Histol"},{"key":"1086_CR29","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s42826-022-00150-3","volume":"38","author":"S Ahmadi-Noorbakhsh","year":"2022","unstructured":"Ahmadi-Noorbakhsh S, Farajli Abbasi M, Ghasemi M, Bayat G, Davoodian N, Sharif-Paghaleh E, Poormoosavi SM, Rafizadeh M, Maleki M, Shirzad-Aski H. Anesthesia and analgesia for common research models of adult mice. Lab Anim Res. 2022;38:40.","journal-title":"Lab Anim Res"},{"key":"1086_CR30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s41232-022-00230-w","volume":"42","author":"MF Farid","year":"2022","unstructured":"Farid MF, Abouelela YS, Yasin NA, Mousa MR, Ibrahim MA, Prince A, Rizk H. A novel cell-free intrathecal approach with PRP for the treatment of spinal cord multiple sclerosis in cats. Inflamm Regeneration. 2022;42:45.","journal-title":"Inflamm Regeneration"},{"key":"1086_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12917-015-0370-4","volume":"11","author":"CE Giraldo","year":"2015","unstructured":"Giraldo CE, \u00c1lvarez ME, Carmona JU. Effects of sodium citrate and acid citrate dextrose solutions on cell counts and growth factor release from equine pure-platelet rich plasma and pure-platelet rich gel. BMC Vet Res. 2015;11:1\u20137.","journal-title":"BMC Vet Res"},{"key":"1086_CR32","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/jog.15232","volume":"48","author":"MS Bostanc\u0131","year":"2022","unstructured":"Bostanc\u0131 MS, Budak \u00d6, \u00c7akiro\u011flu H, G\u00f6k K, K\u00f6se O, \u00c7okluk E. The effect of protection of platelet-rich plasma against experimental ischemia\/reperfusion injury in the rat ovary on in vitro fertilization outcomes. J Obstet Gynecol Res. 2022;48:1390\u20138.","journal-title":"J Obstet Gynecol Res"},{"key":"1086_CR33","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4172\/2155-6156.1000730","volume":"8","author":"NF El-Tahawy","year":"2017","unstructured":"El-Tahawy NF, Rifaai RA, Saber Ea, Saied SR, Ibrahim RA. Effect of platelet rich plasma (PRP) injection on the endocrine pancreas of the experimentally induced diabetes in male albino rats: a histological and immunohistochemical study. J Diabetes Metab. 2017;8:2.","journal-title":"J Diabetes Metab"},{"key":"1086_CR34","doi-asserted-by":"publisher","first-page":"107814","DOI":"10.1016\/j.intimp.2021.107814","volume":"96","author":"SMNA Hafez","year":"2021","unstructured":"Hafez SMNA, Zenhom NM, Abdel-Hamid HA. Effects of platelet rich plasma on experimentally induced diabetic heart injury. Int Immunopharmacol. 2021;96:107814.","journal-title":"Int Immunopharmacol"},{"key":"1086_CR35","doi-asserted-by":"publisher","first-page":"14061","DOI":"10.1038\/s41598-020-70708-5","volume":"10","author":"K Kr\u00e4ker","year":"2020","unstructured":"Kr\u00e4ker K, Herse F, Golic M, Reichhart N, Crespo-Garcia S, Strau\u00df O, Grune J, Kintscher U, Ebrahim M, Bader M. Effects of empagliflozin and target-organ damage in a novel rodent model of heart failure induced by combined hypertension and diabetes. Sci Rep. 2020;10:14061.","journal-title":"Sci Rep"},{"key":"1086_CR36","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12933-019-0964-4","volume":"18","author":"Q Shao","year":"2019","unstructured":"Shao Q, Meng L, Lee S, Tse G, Gong M, Zhang Z, Zhao J, Zhao Y, Li G, Liu T. Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet\/streptozotocin-induced diabetic rats. Cardiovasc Diabetol. 2019;18:165.","journal-title":"Cardiovasc Diabetol"},{"key":"1086_CR37","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00210-015-1134-1","volume":"388","author":"MC Michel","year":"2015","unstructured":"Michel MC, Mayoux E, Vallon V. A comprehensive review of the pharmacodynamics of the SGLT2 inhibitor empagliflozin in animals and humans. Naunyn Schmiedebergs Arch Pharmacol. 2015;388:801\u201316.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"1086_CR38","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.redox.2017.06.009","volume":"13","author":"S Steven","year":"2017","unstructured":"Steven S, Oelze M, Hanf A, Kr\u00f6ller-Sch\u00f6n S, Kashani F, Roohani S, Welschof P, Kopp M, G\u00f6dtel-Armbrust U, Xia N. The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats. Redox Biol. 2017;13:370\u201385.","journal-title":"Redox Biol"},{"key":"1086_CR39","first-page":"405","volume":"42","author":"E Ozcagli","year":"2018","unstructured":"Ozcagli E, Kara M, Kotil T, Fragkiadaki P, Tzatzarakis MN, Tsitsimpikou C, Stivaktakis PD, Tsoukalas D, Spandidos DA, Tsatsakis AM. Sadministration combined with exercise leads to decreased telomerase activity possibly associated with liver aging. Int J Mol Med. 2018;42:405\u201313.","journal-title":"Int J Mol Med"},{"key":"1086_CR40","unstructured":"Leary SL, Underwood W, Anthony R, Cartner S, Corey D, Grandin T, Greenacre C, Gwaltney-Brant S, McCrackin M, Meyer R. AVMA guidelines for the euthanasia of animals: 2013 edition. Schaumburg (IL): American Veterinary Medical Association; 2013."},{"key":"1086_CR41","doi-asserted-by":"publisher","first-page":"e0238123","DOI":"10.1371\/journal.pone.0238123","volume":"15","author":"J Reimer","year":"2020","unstructured":"Reimer J, Schuster C, Knight C, Pang D, Leung V. Intraperitoneal injection of sodium pentobarbital has the potential to elicit pain in adult rats (Rattus norvegicus). PLoS ONE. 2020;15:e0238123.","journal-title":"PLoS ONE"},{"key":"1086_CR42","first-page":"1","volume":"3","author":"AD Azar","year":"2014","unstructured":"Azar AD, Tavakoli F, Moladoust H, Zare A, Sadeghpour A. Echocardiographic evaluation of cardiac function in ischemic rats: value of m-mode echocardiography. Res Cardiovasc Med. 2014;3:1\u20135.","journal-title":"Res Cardiovasc Med"},{"key":"1086_CR43","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s00395-006-0627-y","volume":"102","author":"AB Stein","year":"2007","unstructured":"Stein AB, Tiwari S, Thomas P, Hunt G, Levent C, Stoddard MF, Tang X-L, Bolli R, Dawn B. Effects of anesthesia on echocardiographic assessment of left ventricular structure and function in rats. Basic Res Cardiol. 2007;102:28\u201341.","journal-title":"Basic Res Cardiol"},{"key":"1086_CR44","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1016\/j.echo.2006.06.011","volume":"19","author":"E Plante","year":"2006","unstructured":"Plante E, Lachance D, Roussel \u00c9, Drolet M-C, Arsenault M, Couet J. Impact of anesthesia on echocardiographic evaluation of systolic and diastolic function in rats. J Am Soc Echocardiogr. 2006;19:1520\u20135.","journal-title":"J Am Soc Echocardiogr"},{"key":"1086_CR45","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.3390\/diagnostics14141507","volume":"14","author":"S Mutavdzin Krneta","year":"2024","unstructured":"Mutavdzin Krneta S, Gopcevic K, Stankovic S, Jakovljevic Uzelac J, Todorovic D, Labudovic Borovic M, Rakocevic J, Djuric D. Insights into the cardioprotective effects of pyridoxine treatment in diabetic rats: A study on cardiac oxidative Stress, cardiometabolic Status, and cardiovascular biomarkers. Diagnostics. 2024;14:1507.","journal-title":"Diagnostics"},{"key":"1086_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1746-1596-7-42","volume":"7","author":"AE Rizzardi","year":"2012","unstructured":"Rizzardi AE, Johnson AT, Vogel RI, Pambuccian SE, Henriksen J, Skubitz AP, Metzger GJ, Schmechel SC. Quantitative comparison of immunohistochemical staining measured by digital image analysis versus pathologist visual scoring. Diagn Pathol. 2012;7:1\u201310.","journal-title":"Diagn Pathol"},{"key":"1086_CR47","doi-asserted-by":"publisher","first-page":"1394557","DOI":"10.3389\/fphar.2024.1394557","volume":"15","author":"N Anajirih","year":"2024","unstructured":"Anajirih N, Abdeen A, Taher ES, Abdelkader A, Abd-Ellatieff HA, Gewaily MS, Ahmed NE, Al-Serwi RH, Sorour SM, Abdelkareem HM. Alchemilla vulgaris modulates isoproterenol-induced cardiotoxicity: interplay of oxidative stress, inflammation, autophagy, and apoptosis. Front Pharmacol. 2024;15:1394557.","journal-title":"Front Pharmacol"},{"key":"1086_CR48","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s10741-012-9355-6","volume":"18","author":"C Basso","year":"2013","unstructured":"Basso C, Calabrese F, Angelini A, Carturan E, Thiene G. Classification and histological, immunohistochemical, and molecular diagnosis of inflammatory myocardial disease. Heart Fail Rev. 2013;18:673\u201381.","journal-title":"Heart Fail Rev"},{"key":"1086_CR49","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","volume":"113","author":"BJ Maron","year":"2006","unstructured":"Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB. Contemporary definitions and classification of the cardiomyopathies: an American heart association scientific statement from the Council on clinical cardiology, heart failure and transplantation committee; quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups; and Council on epidemiology and prevention. Circulation. 2006;113:1807\u201316.","journal-title":"Circulation"},{"key":"1086_CR50","doi-asserted-by":"crossref","unstructured":"Ritti\u00e9 L. Method for Picrosirius red-polarization detection of collagen fibers in tissue sections. Fibrosis: Methods Protocols 2017:395\u2013407.","DOI":"10.1007\/978-1-4939-7113-8_26"},{"key":"1086_CR51","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1177\/0300985818825129","volume":"56","author":"N El-Habashi","year":"2019","unstructured":"El-Habashi N, El-Nahass E-S, Abd-Ellatieff H, Saleh A, Abas O, Tsuchiya Y, Fukushi H, Yanai T. Lesions and distribution of viral antigen in the brain of hamsters infected with equine herpesvirus (EHV)\u20139, EHV-1 strain Ab4p, and Zebra-Borne EHV-1. Vet Pathol. 2019;56:691\u2013702.","journal-title":"Vet Pathol"},{"key":"1086_CR52","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jcpa.2020.07.007","volume":"180","author":"H Abd-Ellatieff","year":"2020","unstructured":"Abd-Ellatieff H, Anwar S, Abas O, Abou-Rawash A-R, Fukushi H, Yanai T. Correlation of Immunomodulatory cytokine expression with histopathological changes and viral antigen in a hamster model of equine herpesvirus-9 encephalitis. J Comp Pathol. 2020;180:46\u201354.","journal-title":"J Comp Pathol"},{"key":"1086_CR53","doi-asserted-by":"publisher","first-page":"79","DOI":"10.5152\/eurasianjmed.2021.20051","volume":"53","author":"A Arjmand","year":"2021","unstructured":"Arjmand A, Abedi B, Hosseini SA. Anti-apoptotic effects of resistance training and tribulus terrestris consumption in the heart tissue of rats exposed to Stano. Eurasian J Med. 2021;53:79.","journal-title":"Eurasian J Med"},{"key":"1086_CR54","doi-asserted-by":"publisher","first-page":"732318","DOI":"10.3389\/frph.2021.732318","volume":"3","author":"DL Smit","year":"2021","unstructured":"Smit DL, Voogel A, Heijer, Md. Ronde wd: anabolic androgenic steroids induce reversible left ventricular hypertrophy and cardiac dysfunction. Echocardiography results of the HAARLEM study. Front Reproductive Health. 2021;3:732318.","journal-title":"Front Reproductive Health"},{"key":"1086_CR55","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s11010-016-2872-1","volume":"425","author":"GL Dornelles","year":"2017","unstructured":"Dornelles GL, Bueno A, de Oliveira JS, da Silva AS, Fran\u00e7a RT, da Silva CB, Machado MSN, Petry LS, Abdalla FH, Lhamas CL. Biochemical and oxidative stress markers in the liver and kidneys of rats submitted to different protocols of anabolic steroids. Mol Cell Biochem. 2017;425:181\u20139.","journal-title":"Mol Cell Biochem"},{"key":"1086_CR56","doi-asserted-by":"publisher","first-page":"954030","DOI":"10.3389\/fphar.2022.954030","volume":"13","author":"A Abdelnaby","year":"2022","unstructured":"Abdelnaby A, Abdel-Aleem N, Mansour A, Abdelkader A, Ibrahim AN, Sorour SM, Elgendy E, Bayoumi H, Abdelrahman SM, Ibrahim SF. The combination of tamarindus indica and coenzyme Q10 can be a potential therapy preference to attenuate cadmium-induced hepatorenal injury. Front Pharmacol. 2022;13:954030.","journal-title":"Front Pharmacol"},{"key":"1086_CR57","doi-asserted-by":"publisher","first-page":"626","DOI":"10.3390\/jpm13040626","volume":"13","author":"S Haro Gir\u00f3n","year":"2023","unstructured":"Haro Gir\u00f3n S, Monserrat Sanz J, Ortega MA, Garcia-Montero C, Fraile-Mart\u00ednez O, G\u00f3mez-Lahoz AM, Boaru DL, de Leon-Oliva D, Guijarro LG, Atienza-Perez M. Prognostic value of malondialdehyde (MDA) in the Temporal progression of chronic spinal cord injury. J Personalized Med. 2023;13:626.","journal-title":"J Personalized Med"},{"key":"1086_CR58","doi-asserted-by":"publisher","first-page":"S297","DOI":"10.4103\/JPBS.JPBS_17_19","volume":"11","author":"DA Cherian","year":"2019","unstructured":"Cherian DA, Peter T, Narayanan A, Madhavan SS, Achammada S, Vynat GP. Malondialdehyde as a marker of oxidative stress in periodontitis patients. J Pharm Bioallied Sci. 2019;11:S297\u2013300.","journal-title":"J Pharm Bioallied Sci"},{"key":"1086_CR59","doi-asserted-by":"publisher","first-page":"107","DOI":"10.21608\/esctj.2023.192691.1028","volume":"11","author":"HAA Albaz","year":"2023","unstructured":"Albaz HAA, Elmesallamy GE, El-Akabawy N, Abaza M. Whey protein and anabolic steroids: current trend and future potential effect on the heart. Biochemical, histological, and immunohistochemical study. Egypt Soc Clin Toxicol J. 2023;11:107\u201329.","journal-title":"Egypt Soc Clin Toxicol J"},{"key":"1086_CR60","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.toxrep.2017.05.005","volume":"4","author":"H Arazi","year":"2017","unstructured":"Arazi H, Mohammadjafari H, Asadi A. Use of anabolic androgenic steroids produces greater oxidative stress responses to resistance exercise in strength-trained men. Toxicol Rep. 2017;4:282\u20136.","journal-title":"Toxicol Rep"},{"key":"1086_CR61","doi-asserted-by":"publisher","first-page":"115194","DOI":"10.1016\/j.ecoenv.2023.115194","volume":"262","author":"O Shanab","year":"2023","unstructured":"Shanab O, El-Rayes SM, Khalil WF, Ahmed N, Abdelkader A, Aborayah NH, Atwa AM, Mohammed FI, Nasr HE, Ibrahim SF. Nephroprotective effects of acacia Senegal against aflatoxicosis via targeting inflammatory and apoptotic signaling pathways. Ecotoxicol Environ Saf. 2023;262:115194.","journal-title":"Ecotoxicol Environ Saf"},{"key":"1086_CR62","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.cotox.2017.11.002","volume":"7","author":"K Lingappan","year":"2018","unstructured":"Lingappan K. NF-\u03baB in oxidative stress. Curr Opin Toxicol. 2018;7:81\u20136.","journal-title":"Curr Opin Toxicol"},{"key":"1086_CR63","doi-asserted-by":"crossref","unstructured":"Mowaad NA, Elgohary R, ElShebiney S. Effect of Sand\/or cannabis abuse on hypertrophic mechanism and oxidative stress of male albino rat cardiac tissue in relation to exercise: a sport abuse practice. Cardiovasc Toxicol 2024:1\u201312.","DOI":"10.1007\/s12012-024-09859-0"},{"key":"1086_CR64","doi-asserted-by":"publisher","first-page":"253","DOI":"10.5858\/2001-125-0253-ASAACS","volume":"125","author":"V Fineschi","year":"2001","unstructured":"Fineschi V, Baroldi G, Monciotti F, Reattelli LP, Turillazzi E. Anabolic steroid abuse and cardiac sudden death: a pathologic study. Arch Pathol Lab Med. 2001;125:253\u20135.","journal-title":"Arch Pathol Lab Med"},{"key":"1086_CR65","doi-asserted-by":"publisher","first-page":"e000364","DOI":"10.1161\/JAHA.111.000364","volume":"1","author":"SM Banypersad","year":"2012","unstructured":"Banypersad SM, Moon JC, Whelan C, Hawkins PN, Wechalekar AD. Updates in cardiac amyloidosis: a review. J Am Heart Association. 2012;1:e000364.","journal-title":"J Am Heart Association"},{"key":"1086_CR66","doi-asserted-by":"publisher","first-page":"e202201159","DOI":"10.1083\/jcb.202201159","volume":"221","author":"E Eskandari","year":"2022","unstructured":"Eskandari E, Eaves CJ. Paradoxical roles of caspase-3 in regulating cell survival, proliferation, and tumorigenesis. J Cell Biol. 2022;221:e202201159.","journal-title":"J Cell Biol"},{"key":"1086_CR67","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/cdd.2009.180","volume":"17","author":"M D\u2019amelio","year":"2010","unstructured":"D\u2019amelio M, Cavallucci V, Cecconi F. Neuronal caspase-3 signaling: not only cell death. Cell Death Differ. 2010;17:1104\u201314.","journal-title":"Cell Death Differ"},{"key":"1086_CR68","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s40265-018-0937-z","volume":"78","author":"JE Frampton","year":"2018","unstructured":"Frampton JE. Empagliflozin: a review in type 2 diabetes. Drugs. 2018;78:1037\u201348.","journal-title":"Drugs"},{"key":"1086_CR69","doi-asserted-by":"publisher","first-page":"464","DOI":"10.4330\/wjc.v13.i9.464","volume":"13","author":"R Naito","year":"2021","unstructured":"Naito R, Kasai T. Sodium glucose cotransporter 2 inhibitors: new horizon of the heart failure pharmacotherapy. World J Cardiol. 2021;13:464.","journal-title":"World J Cardiol"},{"key":"1086_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-019-0816-2","volume":"18","author":"C Li","year":"2019","unstructured":"Li C, Zhang J, Xue M, Li X, Han F, Liu X, Xu L, Lu Y, Cheng Y, Li T. SGLT2 Inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart. Cardiovasc Diabetol. 2019;18:1\u201313.","journal-title":"Cardiovasc Diabetol"},{"key":"1086_CR71","doi-asserted-by":"publisher","first-page":"231","DOI":"10.18295\/2075-0528.2796","volume":"9","author":"HA Al-Hadi","year":"2009","unstructured":"Al-Hadi HA, Fox KA. Cardiac markers in the early diagnosis and management of patients with acute coronary syndrome. Sultan Qaboos Univ Med J. 2009;9:231.","journal-title":"Sultan Qaboos Univ Med J"},{"key":"1086_CR72","doi-asserted-by":"crossref","unstructured":"Wang J, Huang X, Liu H, Chen Y, Li P, Liu L, Li J, Ren Y, Huang J, Xiong E. Empagliflozin ameliorates diabetic cardiomyopathy via attenuating oxidative stress and improving mitochondrial function. Oxid Med Cell Longev. 2022;2022:1122494.","DOI":"10.1155\/2022\/1122494"},{"key":"1086_CR73","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.biopha.2018.10.095","volume":"109","author":"C-C Yang","year":"2019","unstructured":"Yang C-C, Chen Y-T, Wallace CG, Chen K-H, Cheng B-C, Sung P-H, Li Y-C, Ko S-F, Chang H-W. Yip H-K: early administration of empagliflozin preserved heart function in cardiorenal syndrome in rat. Biomed Pharmacother. 2019;109:658\u201370.","journal-title":"Biomed Pharmacother"},{"key":"1086_CR74","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1002\/ejhf.1328","volume":"20","author":"S Pabel","year":"2018","unstructured":"Pabel S, Wagner S, Bollenberg H, Bengel P, Kovacs A, Schach C, Tirilomis P, Mustroph J, Renner A, Gummert J. Empagliflozin directly improves diastolic function in human heart failure. Eur J Heart Fail. 2018;20:1690\u2013700.","journal-title":"Eur J Heart Fail"},{"key":"1086_CR75","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1093\/eurheartj\/ehab758","volume":"43","author":"DA Hess","year":"2022","unstructured":"Hess DA, Verma S, Bhatt D, Bakbak E, Terenzi DC, Puar P, Cosentino F. Vascular repair and regeneration in cardiometabolic diseases. Eur Heart J. 2022;43:450\u20139.","journal-title":"Eur Heart J"},{"key":"1086_CR76","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/cvr\/cvx149","volume":"114","author":"E Bertero","year":"2018","unstructured":"Bertero E, Prates Roma L, Ameri P, Maack C. Cardiac effects of SGLT2 inhibitors: the sodium hypothesis. Cardiovascular Res. 2018;114:12\u20138.","journal-title":"Cardiovascular Res"},{"key":"1086_CR77","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.3390\/biomedicines10112933","volume":"10","author":"PA Everts","year":"2022","unstructured":"Everts PA, Mazzola T, Mautner K, Randelli PS, Podesta L. Modifying orthobiological PRP therapies are imperative for the advancement of treatment outcomes in musculoskeletal pathologies. Biomedicines. 2022;10:2933.","journal-title":"Biomedicines"},{"key":"1086_CR78","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1002\/tox.23456","volume":"37","author":"S Yadav","year":"2022","unstructured":"Yadav S, Srivastava S, Singh G. Platelet-rich plasma exhibits anti\u2010inflammatory effect and attenuates cardiomyocyte damage by reducing NF\u2010\u03baB and enhancing VEGF expression in isoproterenol induced cardiotoxicity model. Environ Toxicol. 2022;37:936\u201353.","journal-title":"Environ Toxicol"},{"key":"1086_CR79","doi-asserted-by":"publisher","first-page":"1026641","DOI":"10.3389\/fphar.2022.1026641","volume":"13","author":"Y Jiao","year":"2022","unstructured":"Jiao Y, Zhang Q, Zhang J, Zha Y, Wang J, Li Y, Zhang S. Platelet-rich plasma ameliorates lipopolysaccharide-induced cardiac injury by inflammation and ferroptosis regulation. Front Pharmacol. 2022;13:1026641.","journal-title":"Front Pharmacol"},{"key":"1086_CR80","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.imbio.2012.05.021","volume":"218","author":"C Eken","year":"2013","unstructured":"Eken C, Sadallah S, Martin PJ, Treves S, Schifferli JA. Ectosomes of polymorphonuclear neutrophils activate multiple signaling pathways in macrophages. Immunobiology. 2013;218:382\u201392.","journal-title":"Immunobiology"},{"key":"1086_CR81","first-page":"1976","volume":"127","author":"S Dinkla","year":"2016","unstructured":"Dinkla S, Van Cranenbroek B, Van Der Heijden WA, He X, Wallbrecher R, Dumitriu IE, van der Ven AJ, Bosman GJ, Koenen HJ, Joosten I. Platelet microparticles inhibit IL-17 production by regulatory T cells through P-selectin. Blood J Am Soc Hematol. 2016;127:1976\u201386.","journal-title":"Blood J Am Soc Hematol"},{"key":"1086_CR82","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1160\/th15-05-0389","volume":"115","author":"B Laffont","year":"2016","unstructured":"Laffont B, Corduan A, Rousseau M, Duchez A-C, Lee CHC, Boilard E, Provost P. Platelet microparticles reprogram macrophage gene expression and function. Thromb Haemost. 2016;115:311\u201323.","journal-title":"Thromb Haemost"},{"key":"1086_CR83","doi-asserted-by":"publisher","first-page":"15348","DOI":"10.1038\/s41598-019-51949-5","volume":"9","author":"J-C Hsu","year":"2019","unstructured":"Hsu J-C, Wang C-Y, Su M-YM, Lin L-Y, Yang W-S. Effect of empagliflozin on cardiac function, adiposity, and diffuse fibrosis in patients with type 2 diabetes mellitus. Sci Rep. 2019;9:15348.","journal-title":"Sci Rep"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-026-01086-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-026-01086-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-026-01086-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:42:57Z","timestamp":1781635377000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40360-026-01086-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1086"],"URL":"https:\/\/doi.org\/10.1186\/s40360-026-01086-3","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,23]]},"assertion":[{"value":"27 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animals were treated and used by following ethical approval from the Veterinary Medicine Cairo University Institutional Animal Care and Use Committee (Vet- CU- IACUC) with approval number (Vet CU 03162023676).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors read and approved the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors read and approved the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"48"}}